Influence of ouabain on the cholinergic neurotransmission in the canine trachea
Related Experiment Video
Updated: Jun 27, 2026

In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Y Tsuchiya1, T Hosokawa, Y Kasuya
1Department of Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan.
Abstract:
The effect of ouabain on the cholinergic neurotransmission of the trachea was investigated using isolated tracheal strips in dogs. Tracheal strips without epithelium were suspended in organ chambers filled with modified Krebs-Henseleit solution. Ouabain (3 X 10(-7)-10(-5) M) concentration-dependently caused a slow sustained tracheal contraction. The contractile response was significantly inhibited by 10(-6) M atropine and was enhanced by 10(-8) M physostigmine. The ouabain-induced tracheal contraction was unaffected by 10(-7) M tetrodotoxin, but was significantly reduced by 10(-3) M hemicholinium-3. In superfusion experiments, ouabain (10(-5) M) produced an increase in the ACh release. Superfusion with Ca(++)-free solution almost eradicated the ACh release and abolished the tracheal contraction induced by ouabain. omega-Conotoxin (5 X 10(-8) M), but not nicardipine (10(-6) M), inhibited significantly the increase in ACh release induced by ouabain. These results suggest that the ouabain-induced tracheal contraction may be mainly due to acceleration of presynaptic ACh release by enhancing the influx of Ca++, and the Ca(+)+ entry may occur through the N-type Ca(+)+ channels in the canine airway presynaptic site.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...

